Global Inflammatory Bowel Disease Treatment Market Research Report by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19
Report ID : QR1001270 | Industries : Healthcare | Published On :November 2021 | Page Count : 253Global Inflammatory Bowel Disease Treatment Market
The global Inflammatory Bowel Disease Treatment market size is projected to grow from USD 19200 million in 2020 to USD 27800 million by 2027, at a CAGR of 4.8%. Inflammatory bowel disease (IBD) is a medical illness that causes chronic inflammation of the gastrointestinal system. The two most frequent kinds of inflammatory bowel illness are ulcerative colitis and Crohn's disease. Ulcerative colitis primarily affects the large intestine and anus, causing inflammation and ulcers in the colon and rectum linings.
Market Drivers
People's inconsistent food patterns and unhealthy lifestyles, as well as increased pollution levels, are a few of the primary drivers for the IBD market. Increased alcohol intake and cigarette smoking are also major factors fueling the IBD market.
Impact of COVID-19
The current coronavirus pandemic is a global health emergency caused by COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2. Although COVID-19 causes only mild flu-like symptoms in the majority of patients, the disease can cause serious, often deadly consequences such as progressive pneumonia, acute respiratory distress syndrome, and organ failure caused by hyper inflammation and a cytokine storm syndrome.
Know more about this report: request for sample pages
Market Segmentation
The Global Inflammatory Bowel Disease Treatment Market is segmented into Route of Administration, Distribution Channel. Based on the Route of Administration, the market is segmented into Oral, Injectable. Further, market is segmented into The Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy.
Regional Analysis
Global Inflammatory Bowel Disease Treatment Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America has the largest market share and is expected to dominate the market during the forecast period. Market growth is expected to be driven by increased adoption of strategies such as new product development and expansion. Takeda Pharmaceutical, for example, got U.S. FDA approval in June 2020 to manufacture Entyvio (vedolizumab) in its U.S.-based manufacturing facility. The clearance is expected to help the drug's expanding demand in the United States and neighboring countries. Furthermore, Takeda Pharmaceutical is aggressively investing in the development of the Chinese market.
Key Players
Various key players are listed in this report such as AbbVie Inc., Biogen, Johnson & Johnson Services, Inc., Amgen Inc., UCB S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Pfizer Inc., and Eli Lilly
Market Taxonomy
By Route of Administration
- Oral
- Injectable
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region
- North America
- Latin America
- Europe
- China
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Inflammatory Bowel Disease Treatment Market?
- What will be the growth rate from 2020 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Global Inflammatory Bowel Disease Treatment Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Inflammatory Bowel Disease Treatment Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Inflammatory Bowel Disease Treatment Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Inflammatory Bowel Disease Treatment Market Share Analysis, By Type
5.3 Global Inflammatory Bowel Disease Treatment Market Size and Forecast, By Type
5.3.1 Crohn's Disease
5.3.2 Ulcerative Colitis
6 Global Inflammatory Bowel Disease Treatment Market, By Drug Class
6.1 Y-o-Y Growth Comparison, By Drug Class
6.2 Global Inflammatory Bowel Disease Treatment Market Share Analysis, By Drug Class
6.3 Global Inflammatory Bowel Disease Treatment Market Size and Forecast, By Drug Class
6.3.1 Aminosalicylates
6.3.2. Corticosteroids
6.3.3 TNF inhibitors
6.3.4 IL inhibitors
6.3.5 JAK inhibitors
6.3.6 Anti-integrin
6.3.7 Others
7 Global Inflammatory Bowel Disease Treatment Market, By Route of Administration
7.1 Y-o-Y Growth Comparison, By Route of Administration
7.2 Global Inflammatory Bowel Disease Treatment Market Share Analysis, By Route of Administration
7.3 Global Inflammatory Bowel Disease Treatment Market Size and Forecast, By Route of Administration
7.3.1 Oral
7.3.1 Injectable
8 Global Inflammatory Bowel Disease Treatment Market, By Distribution Channel
8.1 Y-O-Y Growth Comparison, By Distribution Channel
8.2 Global Inflammatory Bowel Disease Treatment Market Share Analysis, By Distribution Channel
8.3 Global Inflammatory Bowel Disease Treatment Market Size and Forecast, By Distribution Channel
8.3.1 Hospital Pharmacy
8.3.2 Retail Pharmacy
8.3.3 Online Pharmacy
9 Global Inflammatory Bowel Disease Treatment Market, By Region
9.1 Global Inflammatory Bowel Disease Treatment Market Share Analysis, By Region
9.2 Global Inflammatory Bowel Disease Treatment Market Share Analysis, By Region
9.3 Global Inflammatory Bowel Disease Treatment Market Size and Forecast, By Region
10 North America Inflammatory Bowel Disease Treatment Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 North America Inflammatory Bowel Disease Treatment Market Share Analysis, By Type
10.3 North America Inflammatory Bowel Disease Treatment Market Size and Forecast, By Drug Class
10.4 North America Inflammatory Bowel Disease Treatment Market Size and Forecast, By Route of Administration
10.5 North America Inflammatory Bowel Disease Treatment Market Size and Forecast, By Distribution Channel
10.6 North America Inflammatory Bowel Disease Treatment Market Size and Forecast, By Country
10.7.1 U.S.
10.7.2 Canada
10.7.3 Mexico
11 Europe Inflammatory Bowel Disease Treatment Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Europe Inflammatory Bowel Disease Treatment Market Share Analysis, By Type
11.3 Europe Inflammatory Bowel Disease Treatment Market Size and Forecast, By Drug Class
11.4 Europe Inflammatory Bowel Disease Treatment Market Size and Forecast, By Route of Administration
11.5 Europe Inflammatory Bowel Disease Treatment Market Size and Forecast, By Distribution Channel
11.6 Europe Inflammatory Bowel Disease Treatment Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4. Rest of Europe
12 Asia Pacific Inflammatory Bowel Disease Treatment Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Asia Pacific Inflammatory Bowel Disease Treatment Market Share Analysis, By Type
12.3 Asia Pacific Inflammatory Bowel Disease Treatment Market Size and Forecast, By Drug Class
12.4 Asia Pacific Inflammatory Bowel Disease Treatment Market Size and Forecast, By Route of Administration
12.5 Asia Pacific Inflammatory Bowel Disease Treatment Market Size and Forecast, By Distribution Channel
12.6 Asia Pacific Inflammatory Bowel Disease Treatment Market Size and Forecast, By Country
12.6.1 China
12.7.2 Japan
12.8.3 India
12.9.4. Rest of Asia Pacific
13 Latin America Inflammatory Bowel Disease Treatment Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Latin America Inflammatory Bowel Disease Treatment Market Share Analysis, By Type
13.3 Latin America Inflammatory Bowel Disease Treatment Market Size and Forecast, By Drug Class
13.4 Latin America Inflammatory Bowel Disease Treatment Market Size and Forecast, By Route of Administration
13.5 Latin America Inflammatory Bowel Disease Treatment Market Size and Forecast, By Distribution Channel
13.6 Latin America Inflammatory Bowel Disease Treatment Market Size and Forecast, Country
13.7.1. Brazil
13.8.2. Rest of Latin America
14 Middle East Inflammatory Bowel Disease Treatment Market Analysis and Forecast (2021-2027)
14.1 Introduction
14.2 Middle East Inflammatory Bowel Disease Treatment Market Share Analysis, By Type
14.3 Middle East Inflammatory Bowel Disease Treatment Market Size and Forecast, By Drug Class
14.4 Middle East Inflammatory Bowel Disease Treatment Market Size and Forecast, By Route of Administration
14.5 Middle East Inflammatory Bowel Disease Treatment Market Size and Forecast, By Distribution Channel
14.6 Middle East Inflammatory Bowel Disease Treatment Market Size and Forecast, By Country
14.7.1. Saudi Arabia
14.8.2. UAE
14.9.3. Egypt
14.10.4. Kuwait
14.11.5. South Africa
15Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 AbbVie Inc
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2. Biogen
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3. Johnson & Johnson Services, Inc
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Amgen Inc
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 UCB S.A
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Novartis AG
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Takeda Pharmaceutical Company Limited
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Merck & Co., Inc.
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Pfizer Inc
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Eli Lilly
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies